Why Jasper Therapeutics Stock Is Jumping Today

Shares of Jasper Therapeutics (NASDAQ: JSPR) were up 117.8% as of 10:39 a.m. EDT on Wednesday after the company received some affection from Wall Street. Oppenheimer initiated coverage of the small clinical-stage biopharmaceutical company with an outperform rating and a huge price target. 

Oppenheimer thinks Jasper Therapeutics stock can keep rising above today's enormous gain. The bank initiated coverage with an eye-popping price target of $21 per share, or around 191% above its price at the end of yesterday's trading. 

Image source: Getty Images.

Continue reading

Source Fool.com